By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Ambry Genetics has been named a certified service provider for several product offerings from Roche NimbleGen.

Aliso Viejo, Calif.-based Ambry will offer services using Nimblegen's comparative genomic hybridization, chromatin immunoprecipitation-on-chip, DNA methylation, and gene expression tools. The addition of these applications means that Ambry is now certified on all Roche NimbleGen applications, Roche said today.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Science speaks with the University of Michigan's Jedidiah Carlson, who has tracked population genetic discussions at white nationalist sites.

Gene therapies could qualify for a faster US Food and Drug Administration approval process, according to Stat News.

NPR reports that the US House of Representatives has passed a bill to enable terminally ill patients access to experimental drugs.

In Genome Research this week: inversion variants mapped in human, non-human primate genomes; transcriptome profiling of maize, sorghum; and more.

Jun
19
Sponsored by
Advanced Cell Diagnostics

This webinar will provide evidence for the use of RNA in situ hybridization (RNA ISH) as a replacement for immunohistochemistry (IHC) in cancer research and diagnostic applications.

Jun
21
Sponsored by
Roche

This webinar will provide a detailed look at how a genomics lab implemented next-generation sequencing (NGS) liquid biopsy assays into its in-house clinical research program.